Cardiometabolic risk simply includes a series of cardiovascular factors and a series of metabolic risk factors. Less easy to determine, is exactly what we can do that will effectively and efficiently reduce this risk. Dr. Karol Watson, associate professor of medicine at the University of California, Los Angeles (UCLA) David Geffen School of Medicine, and director of the UCLA Cholesterol and Lipid Management Center, takes a look at what is working, as well as the areas where we can make more progress toward suppressing the drivers of cardiovascular and metabolic diseases. Dr. Larry Kaskel hosts.
Brought to you by:
